GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Accounts Payable

KPC Pharmaceuticals (SHSE:600422) Accounts Payable : ¥1,060 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Accounts Payable?

KPC Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was ¥1,060 Mil.

KPC Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2023 (¥902 Mil) to Dec. 2023 (¥933 Mil) and increased from Dec. 2023 (¥933 Mil) to Mar. 2024 (¥1,060 Mil).

KPC Pharmaceuticals's annual Accounts Payable declined from Dec. 2021 (¥1,239 Mil) to Dec. 2022 (¥977 Mil) and declined from Dec. 2022 (¥977 Mil) to Dec. 2023 (¥933 Mil).

KPC Pharmaceuticals Accounts Payable Historical Data

The historical data trend for KPC Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Accounts Payable Chart

KPC Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 749.36 823.70 1,238.51 977.12 932.69

KPC Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,063.29 924.34 901.95 932.69 1,060.11

KPC Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

KPC Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

KPC Pharmaceuticals (SHSE:600422) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Accounts Payable
Comparable Companies
SZSE:000623 SZSE:002737 SZSE:000739 SHSE:688192 SHSE:603858 SHSE:600750 SZSE:301015 SHSE:600867 SZSE:300558 SHSE:600420 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
Website
http://www.kpc.com.cn
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals (SHSE:600422) Headlines

No Headlines